Vericel Corp. (VCEL)
57.42
-2.03
(-3.41%)
USD |
NASDAQ |
Nov 12, 16:00
57.40
-0.02
(-0.03%)
After-Hours: 20:00
Vericel Market Cap : 2.931B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 2.931B |
| November 11, 2026 | 3.035B |
| November 10, 2026 | 3.013B |
| November 09, 2026 | 2.980B |
| November 06, 2026 | 2.788B |
| November 05, 2026 | 2.643B |
| November 04, 2026 | 2.321B |
| November 03, 2026 | 2.097B |
| November 02, 2026 | 2.073B |
| October 30, 2026 | 2.060B |
| October 29, 2026 | 2.196B |
| October 28, 2026 | 2.103B |
| October 27, 2026 | 2.214B |
| October 26, 2026 | 2.202B |
| October 23, 2026 | 2.176B |
| October 22, 2026 | 2.199B |
| October 21, 2026 | 2.095B |
| October 20, 2026 | 2.077B |
| October 19, 2026 | 2.066B |
| October 16, 2026 | 2.053B |
| October 15, 2026 | 2.099B |
| October 14, 2026 | 2.060B |
| October 13, 2026 | 2.062B |
| October 12, 2026 | 2.079B |
| October 09, 2026 | 2.052B |
| Date | Value |
|---|---|
| October 08, 2026 | 2.049B |
| October 07, 2026 | 2.085B |
| October 06, 2026 | 2.049B |
| October 05, 2026 | 2.102B |
| October 02, 2026 | 2.055B |
| October 01, 2026 | 2.018B |
| September 30, 2026 | 2.054B |
| September 29, 2026 | 2.078B |
| September 28, 2026 | 2.059B |
| September 25, 2026 | 2.032B |
| September 24, 2026 | 2.011B |
| September 23, 2026 | 1.985B |
| September 22, 2026 | 2.058B |
| September 21, 2026 | 2.024B |
| September 18, 2026 | 2.048B |
| September 17, 2026 | 2.048B |
| September 16, 2026 | 2.058B |
| September 15, 2026 | 2.033B |
| September 14, 2026 | 2.026B |
| September 11, 2026 | 1.962B |
| September 10, 2026 | 1.938B |
| September 09, 2026 | 1.995B |
| September 08, 2026 | 2.000B |
| September 04, 2026 | 2.057B |
| September 03, 2026 | 2.071B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.134B |
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| Anika Therapeutics, Inc. | 184.97M |
| Savara, Inc. | 970.13M |
| Biogen, Inc. | 37.02B |
Market Cap Related Metrics
| PE Ratio | 90.87 |
| PS Ratio | 9.216 |
| PEG Ratio | 0.5595 |
| Price to Book Value | 7.629 |
| Price to Free Cash Flow | 51.60 |
| Price | 57.42 |
| Earnings Yield | 1.10% |
| PEGY Ratio | 0.5595 |
| Operating PE Ratio | 110.77 |
| Normalized PE Ratio | 90.88 |